In non-obese subjects, elevated ALT and TG levels, a higher degree of insulin resistance, increased waist circumstance, body weight change and an age between 40 and 64 years were identified as the risk factors for NAFLD [5, 28]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.